MAPT and Alzheimer disease: Therefore, based on the accumulated evidence, we speculated on the neurological mechanisms by which AAI affects AD-related pathologies, such as Aβ deposition, tau hyperphosphorylation, neuroinflammation, and impaired AHN (Figure 1).